cannabis indica

Índice completo — página 51 de 77

Estudos 5.001 a 5.100 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2017. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 5.001 a 5.100

  1. 2017

    Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal Δ 9-THC exposure

  2. 2017

    Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial

  3. 2017

    Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial

  4. 2017

    Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells

    InconclusivoEstudo LaboratorialLisofosfatidilinositol (LPI)
  5. 2017

    Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review.

  6. 2017

    Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database.

    FavorávelMetanáliseDoenças Cardiovasculares (DCV)
  7. 2017

    Masturbation to Orgasm Stimulates the Release of the Endocannabinoid 2-Arachidonoylglycerol in Humans.

    FavorávelEnsaio Clínico Duplo-CegoLibidoDisfunção ErétilAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  8. 2017

    Medical Cannabinoids in Children and Adolescents: A Systematic Review.

    FavorávelMetanáliseDorEpilepsiaNáusea e Vômito+3
  9. 2017

    Medical cannabis and mental health: A guided systematic review.

    FavorávelMetanáliseTEPT
  10. 2017

    Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation

    FavorávelMetanáliseDistoniaCoreiaBlefaroespasmo
  11. 2017

    Medical cannabis: Another piece in the mosaic of autoimmunity?

    FavorávelMetanáliseInflamaçãoEsclerose MúltiplaDiabetes+4
  12. 2017

    Medical use of cannabis in Switzerland: analysis of approved exceptional licences.

  13. 2017

    Micronized palmitoylethanolamide/trans-polydatin treatment of endometriosis-related pain: a meta-analysis

    FavorávelMetanáliseDorDor — CrônicaEndometriosePalmitoiletanolamida (PEA)
  14. 2017

    Modulation of Human Peripheral Blood Mononuclear Cell Signaling by Medicinal Cannabinoids.

    FavorávelEnsaio Clínico Duplo-CegoPancreatiteTetraidrocanabinol (THC)
  15. 2017

    Molecular Targets of the Phytocannabinoids-A Complex Picture

    InconclusivoMetanáliseTetraidrocanabinol (THC)Canabigerol (CBG)+4
  16. 2017

    N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformation by Suppressing Its Plasma Membrane Translocation

    FavorávelEstudo LaboratorialCâncerN-Araquidonoil Dopamina (NADA)
  17. 2017

    N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via Nonhematopoietic TRPV1

    FavorávelEstudo LaboratorialInflamaçãoN-Araquidonoil Dopamina (NADA)
  18. 2017

    N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities

    FavorávelEstudo LaboratorialDorInflamaçãoDor — CrônicaN-Araquidonoil Dopamina (NADA)+2
  19. 2017

    Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study

  20. 2017

    Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids

    FavorávelMetanáliseCâncerCâncer — Pulmão
  21. 2017

    Natural (∆9-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor

  22. 2017

    Nerolidol and Farnesol Inhibit Some Cytochrome P450 Activities but Did Not Affect Other Xenobiotic-Metabolizing Enzymes in Rat and Human Hepatic Subcellular Fractions

    InconclusivoEstudo Laboratorial
  23. 2017

    Neurological Aspects Of Medical Use Of Cannabidiol

    FavorávelMetanáliseEpilepsiaDisfunção CognitivaEsclerose Múltipla+5
  24. 2017

    Neuroprotective Effect of β-Caryophyllene on Cerebral Ischemia-Reperfusion Injury via Regulation of Necroptotic Neuronal Death and Inflammation: In Vivo and in Vitro

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Doenças NeurodegenerativasAVC+1
  25. 2017

    Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease. Induced by MPTP.

    FavorávelEstudo em AnimaisDoença de ParkinsonCanabinoides Sintéticos AM-x
  26. 2017

    Neuroprotective Properties of Endocannabinoids N-Arachidonoyl Dopamine and N-Docosahexaenoyl Dopamine Examined in Neuronal Precursors Derived from Human Pluripotent Stem Cells

    FavorávelEstudo LaboratorialEstresse OxidativoN-Araquidonoil Dopamina (NADA)
  27. 2017

    Neurosteroid Levels in Patients With Bipolar Disorder and a History of Cannabis Use Disorders

  28. 2017

    Newborn birth-weight of pregnant women on methadone or buprenorphine maintenance treatment: A national contingency management approach trial

    InconclusivoEnsaio ClínicoDependência QuímicaDependência — CannabisDepressão+6
  29. 2017

    No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).

    InconclusivoMetanáliseHIV/AIDS
  30. 2017

    Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation

    InconclusivoEstudo em AnimaisGestaçãoEndocanabinoide (não especificado)
  31. 2017

    Obesity-Related CKD: When Kidneys Get the Munchies

    InconclusivoMetanáliseObesidadeDoença Renal Crônica
  32. 2017

    Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.

  33. 2017

    Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation.

    FavorávelEstudo em AnimaisEsclerose MúltiplaDiabetesArtriteTetraidrocanabinol (THC)+1
  34. 2017

    Palmitoylethanolamide and Polydatin combination reduces inflammation and oxidative stress in vascular injury

  35. 2017

    Pediatric Concerns Due to Expanded Cannabis Use: Unintended Consequences of Legalization

    DesfavorávelMetanáliseEfeitos Adversos da CannabisEpilepsiaGestação+1
  36. 2017

    Perillyl Alcohol Protects Human Renal Tubular Epithelial Cells From Hypoxia/Reoxygenation Injury via Inhibition of ROS, Endoplasmic Reticulum Stress and Activation of PI3K/Akt/eNOS Pathway

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)Estresse OxidativoLesão de Reperfusão
  37. 2017

    Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling

    FavorávelEstudo em AnimaisObesidadeCanabinoide Sintético (não especificado)
  38. 2017

    Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication

  39. 2017

    Pharmacokinetic Evaluation of β-Caryophyllene Alcohol in Rats and Beagle Dogs

    InconclusivoEstudo em AnimaisInflamaçãoAplicações VeterináriasAsma
  40. 2017

    Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  41. 2017

    Phycocyanin: A Potential Drug for Cancer Treatment

    FavorávelMetanáliseCâncerInflamaçãoEstresse OxidativoFicocianina
  42. 2017

    Phytol Induces ROS Mediated Apoptosis by Induction of Caspase 9 and 3 Through Activation of TRAIL, FAS and TNF Receptors and Inhibits Tumor Progression Factor Glucose 6 Phosphate Dehydrogenase in Lung Carcinoma Cell Line (A549)

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  43. 2017

    Plastic And Neuroprotective Mechanisms Involved In The Therapeutic Effects Of Cannabidiol In Psychiatric Disorders

    FavorávelMetanáliseAnsiedadeDepressãoPsicose+2
  44. 2017

    Polyunsaturated Fatty Acids Differentially Modulate Cell Proliferation and Endocannabinoid System in Two Human Cancer Lines

    FavorávelEstudo LaboratorialCâncerCâncer — MamaCâncer — CérebroÔmega-3Ômega-6
  45. 2017

    Pooled analysis of three randomized, double-blind, placebo controlled trials with rimonabant for smoking cessation

  46. 2017

    Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis.

    FavorávelEstudo LaboratorialEsclerose MúltiplaCanabinoide Sintético (não especificado)
  47. 2017

    Potential of Cannabidiol for the Treatment of Viral Hepatitis

    FavorávelEstudo LaboratorialHepatite
  48. 2017

    Preliminary Evidence On Cannabis Effectiveness And Tolerability For Adults With Tourette Syndrome

    FavorávelMetanáliseTiques e Síndrome de Tourette
  49. 2017

    Prevalence and Patterns of Marijuana Use in Young Adults With Inflammatory Bowel Disease.

  50. 2017

    Propofol-based anaesthesia versus sevoflurane-based anaesthesia for living donor kidney transplantation: results of the VAPOR-1 randomized controlled trial

  51. 2017

    Propranolol Treatment of Cannabinoid Hyperemesis Syndrome: A Case Report

  52. 2017

    Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy.

    FavorávelEstudo em AnimaisEpilepsiaDoenças Neurodegenerativas
  53. 2017

    Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol.

    FavorávelMetanáliseEpilepsia
  54. 2017

    Quantitative Analyses Of Synergistic Responses Between Cannabidiol And DNA-damaging Agents On The Proliferation And Viability Of Glioblastoma And Neural Progenitor Cells In Culture

    FavorávelEstudo LaboratorialCâncerCâncer — Cérebro
  55. 2017

    Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome

  56. 2017

    RECAST (Remote Ischemic Conditioning After Stroke Trial): A Pilot Randomized Placebo Controlled Phase II Trial in Acute Ischemic Stroke

  57. 2017

    Recent advances in the endocrinology of the sebaceous gland

  58. 2017

    Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life

    FavorávelMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+4
  59. 2017

    Regulation Of Human Glioblastoma Cell Death By Combined Treatment Of Cannabidiol, γ-radiation And Small Molecule Inhibitors Of Cell Signaling Pathways

    FavorávelEstudo LaboratorialCâncerCâncer — CérebroSíndrome Aguda da Radiação
  60. 2017

    Relationship Between Frequent Recreational Cannabis (Marijuana and Hashish) Use and Periodontitis in Adults in the United States: National Health and Nutrition Examination Survey 2011 to 2012

    DesfavorávelMetanáliseDoença Periodontal
  61. 2017

    Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy

    FavorávelMetanáliseEpilepsia
  62. 2017

    Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series

    InconclusivoMetanáliseSíndrome da Hiperêmese CanabinoideCapsaicina (CAPS)
  63. 2017

    Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin

  64. 2017

    Risk of neonatal and childhood morbidity among preterm infants exposed to marijuana

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisDoenças NeurodegenerativasGestação+3
  65. 2017

    Role of cannabis in cardiovascular disorders.

  66. 2017

    Role of Endocannabinoids on Neuroinflammation in Autism Spectrum Disorder Prevention.

    FavorávelMetanáliseAutismoEndocanabinoide (não especificado)
  67. 2017

    Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)

    FavorávelMetanáliseEsclerose MúltiplaTHC:CBD Farmacêutico
  68. 2017

    Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies

    InconclusivoMetanálise ClínicaDorDor — OncológicaTetraidrocanabinol (THC)THC:CBD Farmacêutico
  69. 2017

    Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients

    FavorávelEnsaio ClínicoDorInflamaçãoDor — CrônicaTHC:CBD Farmacêutico+2
  70. 2017

    Schizophrenia and depression, two poles of endocannabinoid system deregulation.

  71. 2017

    Seeking new acne treatment from natural products, devices and synthetic drug discovery

    FavorávelMetanáliseInflamaçãoAcne
  72. 2017

    Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis

  73. 2017

    Severity and outcomes of acute alcoholic pancreatitis in cannabis users.

    FavorávelMetanálisePancreatite
  74. 2017

    Single and combined effects of Δ9 -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain.

  75. 2017

    Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology

    FavorávelEnsaio ClínicoInflamaçãoAnsiedadeDepressãoTHC:CBD Farmacêutico+4
  76. 2017

    Smoked marijuana attenuates performance and mood disruptions during simulated night shift work.

    FavorávelEnsaio Clínico Duplo-CegoInsônia e Distúrbios do SonoTetraidrocanabinol (THC)
  77. 2017

    Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients

    FavorávelMetanáliseTiques e Síndrome de TouretteTHC Farmacêutico
  78. 2017

    Spice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury Attributable to the Use of Synthetic Cannabis

  79. 2017

    Standardized Cannabis sativa Extract Attenuates Tau and Stathmin Gene Expression in the Melanoma Cell Line

    FavorávelEstudo LaboratorialCâncerCâncer — MelanomaCâncer — Metastático
  80. 2017

    Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia.

  81. 2017

    Strokes are possible complications of cannabinoids use

    InconclusivoMetanáliseAVCIntoxicação por Cannabis Sintética
  82. 2017

    Substance Use Among Homeless Individuals With Schizophrenia and Bipolar Disorder

    DesfavorávelMetanáliseDependência — CannabisPsicoseDependência — Opioides+5
  83. 2017

    Substitution Of Medical Cannabis For Pharmaceutical Agents For Pain, Anxiety, And Sleep

    FavorávelMetanáliseDorAnsiedadeInsônia e Distúrbios do Sono
  84. 2017

    Suppression of inflammatory and infection responses in lung macrophages by eucalyptus oil and its constituent 1,8-cineole: Role of pattern recognition receptors TREM-1 and NLRP3, the MAP kinase regulator MKP-1, and NFκB

    FavorávelEstudo LaboratorialAsmaDPOCTosse
  85. 2017

    Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations

  86. 2017

    Survey Report on Parents and Patients Related to the Use of Cannabidiol Symptomatic Epilepsy Secondary to Tuberous Sclerosis Complex (TSC) in Mexico

    FavorávelMetanáliseEpilepsiaEpilepsia — Lennox-Gastaut
  87. 2017

    Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease

  88. 2017

    Symptoms of obsessive-compulsive disorder predict cannabis misuse

    DesfavorávelMetanáliseTOC
  89. 2017

    Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset

  90. 2017

    Synthetic Cannabis Analogues and Suicidal Behavior: Case Report

  91. 2017

    Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges.

  92. 2017

    Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy.

    FavorávelEstudo em AnimaisTosseAnandamida (AEA)Endocanabinoide (não especificado)+2
  93. 2017

    Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid Nanoparticles

    FavorávelEstudo em AnimaisDepressãoCanabinoides Sintéticos HU-xCúrcuma
  94. 2017

    Terpene Synthases From Cannabis Sativa

    InconclusivoEstudo Laboratorial
  95. 2017

    Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information

  96. 2017

    Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.

  97. 2017

    The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis

  98. 2017

    The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer

    FavorávelEstudo LaboratorialCâncerCâncer — Pâncreas
  99. 2017

    The cannabinoid beta-caryophyllene (BCP) induces neuritogenesis in PC12 cells by a cannabinoid-receptor-independent mechanism.

    FavorávelEstudo LaboratorialEstresse OxidativoDoenças Neurodegenerativas
  100. 2017

    The cannabinoid system and pain.